Skip to main content

Table 1 Patients' clinical and pathological characteristics

From: Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer

Variable Subgroup n(%)
age (years) ≤ 65 31 (44.3)
range 47-75 > 65 39 (55.7)
pre-op PSA (ng/ml) < 5 14 (20.0)
range 2.8-23.9 5-10 48 (68.6)
  > 10 8 (11.4)
pT stage ≤ 2 42 (60.0)
  > 2 28 (40.0)
Gleason score ≤ 7 (3+4) 50 (46.8)
  ≥ 7 (4+3) 20 (44.2)
  1. pre-op PSA, pre-operative PSA; pT stage, pathologic TNM stage